Sign Up to like & get
recommendations!
3
Published in 2023 at "European journal of heart failure"
DOI: 10.1002/ejhf.2857
Abstract: BACKGROUND In the EMPEROR-Preserved trial, empagliflozin improved clinical outcomes of patients with heart failure with preserved ejection fraction. In this pre-specified analysis, we aim to study the effect of empagliflozin on cardiovascular and kidney outcomes…
read more here.
Keywords:
emperor preserved;
heart failure;
without ckd;
kidney ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.05.057
Abstract: BACKGROUND The optimal revascularization strategy for patients with left main coronary artery disease (LMCAD) and chronic kidney disease (CKD) remains unclear. OBJECTIVES This study investigated the comparative effectiveness of percutaneous coronary intervention (PCI) versus coronary…
read more here.
Keywords:
left main;
trial;
without ckd;
cabg patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Nephron"
DOI: 10.1159/000528080
Abstract: BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is suggested as a risk factor for chronic kidney disease (CKD). The incidence of NAFLD is rising globally in parallel to the increasing incidences of obesity and type 2…
read more here.
Keywords:
patients type;
nonalcoholic fatty;
without ckd;
disease ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Diabetes care"
DOI: 10.2337/dc22-0224
Abstract: OBJECTIVE To evaluate trends in antidiabetic medication initiation patterns among patients with type 2 diabetes mellitus (T2DM) with and without chronic kidney disease (CKD). RESEARCH DESIGN AND METHODS A retrospective cohort study using the UK…
read more here.
Keywords:
patients type;
without ckd;
without chronic;
type diabetes ... See more keywords